All FDA-approved EMA-approved PMDA-approved
Target Card Uniprot Example: P23975

copper sulfate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4282	7758-99-8

Description:

Molecule	Description
Synonyms: cupric sulfate copper sulfate copper sulfate pentahydrate cupric sulfate pentahydrate cupric sulfate anhydrous	A sulfate salt of copper. It is a potent emetic and is used as an antidote for poisoning by phosphorus. It also can be used to prevent the growth of algae. Molecular weight: 159.60 Formula: CuO4S CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: ALOGS: ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
May 5, 1987	FDA	ABRAXIS PHARM

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Respiratory tract infection bacterial	109.76	105.67	17	204	1449	31695674

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Respiratory tract infection bacterial	111.87	55.91	17	346	1720	70926361
Respiratory tract infection viral	99.77	55.91	17	346	3524	70924557
Respiratory tract infection	62.19	55.91	18	345	42380	70885701

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	V03AB20	VARIOUS ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS Antidotes
CHEBI has role	CHEBI:33287	fertilizers
CHEBI has role	CHEBI:139492	sensitizers
CHEBI has role	CHEBI:149552	emetics
MeSH PA	D000931	Antidotes
MeSH PA	D002491	Central Nervous System Agents
MeSH PA	D004639	Emetics
MeSH PA	D005765	Gastrointestinal Agents
MeSH PA	D018373	Peripheral Nervous System Agents
MeSH PA	D020011	Protective Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Hypocupremia	contraindication	19577007
Wilson's disease	contraindication	88518009

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

Formulation strength	Trade name	Applicant	Application number	Approval date	Type	Dose form	Route	Exclusivity date	Description
EQ 0.3MG COPPER/ML;EQ 55MCG BASE/ML;EQ 60MCG SELENIUM/ML;EQ 3MG BASE/ML (1ML)	TRALEMENT	AM REGENT	N209376	July 2, 2020	RX	SOLUTION	INTRAVENOUS	April 30, 2024	NEW CHEMICAL ENTITY
EQ 0.3MG COPPER/ML;EQ 55MCG BASE/ML;EQ 60MCG SELENIUM/ML;EQ 3MG BASE/ML (5ML)	TRALEMENT	AM REGENT	N209376	Dec. 2, 2020	RX	SOLUTION	INTRAVENOUS	April 30, 2024	NEW CHEMICAL ENTITY
EQ 60MCG COPPER/ML;EQ 3MCG BASE/ML;EQ 6MCG SELENIUM/ML;EQ 1000MCG BASE/ML (1ML)	MULTRYS	AM REGENT	N209376	June 30, 2021	RX	SOLUTION	INTRAVENOUS	April 30, 2024	NEW CHEMICAL ENTITY

Bioactivity Summary:

None

External reference:

ID	Source
4020097	VUID
N0000148098	NUI
D03613	KEGG_DRUG
7758-98-7	SECONDARY_CAS_RN
4017628	VANDF
4017650	VANDF
4017708	VANDF
4020097	VANDF
C0056301	UMLSCUI
CHEBI:23414	CHEBI
CHEMBL604	ChEMBL_ID
D019327	MESH_DESCRIPTOR_UI
DB06778	DRUGBANK_ID
24462	PUBCHEM_CID
1999541	RXNORM
3686	MMSL
37539	MMSL
39943	MMSL
4503	MMSL
4513	MMSL
6110	MMSL
72601	MMSL
d04204	MMSL
000855	NDDF
001946	NDDF
007446	NDDF
423960007	SNOMEDCT_US
70168001	SNOMEDCT_US
LRX7AJ16DT	UNII

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Multitrace-4 Neonatal	HUMAN PRESCRIPTION DRUG LABEL	4	0517-6202	INJECTION, SOLUTION	0.39 mg	INTRAVENOUS	UNAPPROVED DRUG OTHER	14 sections
Multitrace-5	HUMAN PRESCRIPTION DRUG LABEL	5	0517-8201	INJECTION, SOLUTION, CONCENTRATE	3.93 mg	INTRAVENOUS	UNAPPROVED DRUG OTHER	14 sections
Multitrace-5	HUMAN PRESCRIPTION DRUG LABEL	5	0517-8210	INJECTION, SOLUTION, CONCENTRATE	3.93 mg	INTRAVENOUS	UNAPPROVED DRUG OTHER	14 sections
Multitrace-5	HUMAN PRESCRIPTION DRUG LABEL	5	0517-8510	INJECTION, SOLUTION	1.57 mg	INTRAVENOUS	UNAPPROVED DRUG OTHER	14 sections
Multitrace -4 Pediatric	HUMAN PRESCRIPTION DRUG LABEL	4	0517-9203	INJECTION, SOLUTION, CONCENTRATE	0.40 mg	INTRAVENOUS	UNAPPROVED DRUG OTHER	14 sections
Multrys	HUMAN PRESCRIPTION DRUG LABEL	4	0517-9302	INJECTION, SOLUTION	150 ug	INTRAVENOUS	NDA	19 sections
Tralement	HUMAN PRESCRIPTION DRUG LABEL	4	0517-9305	INJECTION, SOLUTION	0.30 mg	INTRAVENOUS	NDA	22 sections
Trace Elements 4	HUMAN PRESCRIPTION DRUG LABEL	4	0517-9310	INJECTION, SOLUTION	0.40 mg	INTRAVENOUS	UNAPPROVED DRUG OTHER	14 sections
Strovite One Caplets	HUMAN PRESCRIPTION DRUG LABEL	20	0642-0207	TABLET	1.50 mg	ORAL	UNAPPROVED DRUG OTHER	14 sections
Se-Tan PLUS	HUMAN PRESCRIPTION DRUG LABEL	13	13925-118	CAPSULE, GELATIN COATED	0.80 mg	ORAL	unapproved drug other	19 sections
Se-Tan PLUS	HUMAN PRESCRIPTION DRUG LABEL	13	13925-118	CAPSULE, GELATIN COATED	0.80 mg	ORAL	unapproved drug other	19 sections
Quflora Pediatric Drops	HUMAN PRESCRIPTION DRUG LABEL	13	15370-100	LIQUID	1 mg	ORAL	UNAPPROVED DRUG OTHER	11 sections
Quflora Pediatric Drops	HUMAN PRESCRIPTION DRUG LABEL	13	15370-101	LIQUID	1 mg	ORAL	UNAPPROVED DRUG OTHER	11 sections
Quflora Pediatric	HUMAN PRESCRIPTION DRUG LABEL	14	15370-103	TABLET, CHEWABLE	1 mg	ORAL	UNAPPROVED DRUG OTHER	12 sections
Quflora Pediatric	HUMAN PRESCRIPTION DRUG LABEL	14	15370-104	TABLET, CHEWABLE	1 mg	ORAL	UNAPPROVED DRUG OTHER	12 sections
Quflora Pediatric	HUMAN PRESCRIPTION DRUG LABEL	14	15370-105	TABLET, CHEWABLE	1 mg	ORAL	UNAPPROVED DRUG OTHER	12 sections
Centratex	HUMAN PRESCRIPTION DRUG LABEL	13	23359-100	CAPSULE	0.80 mg	ORAL	unapproved drug other	13 sections
C-Nate DHA	HUMAN PRESCRIPTION DRUG LABEL	13	23359-105	CAPSULE, GELATIN COATED	1 mg	ORAL	unapproved drug other	15 sections
Dynamiclear Rapid	HUMAN OTC DRUG LABEL	3	49836-033	LIQUID	40 mg	TOPICAL	EXPORT ONLY	15 sections
Dynamiclear Rapid	HUMAN OTC DRUG LABEL	3	49836-034	LIQUID	40 mg	TOPICAL	EXPORT ONLY	15 sections
Concept OB	HUMAN PRESCRIPTION DRUG LABEL	15	52747-620	CAPSULE	800 ug	ORAL	unapproved drug other	13 sections
Concept OB	HUMAN PRESCRIPTION DRUG LABEL	15	52747-620	CAPSULE	800 ug	ORAL	unapproved drug other	13 sections
Concept DHA	HUMAN PRESCRIPTION DRUG LABEL	15	52747-621	CAPSULE, LIQUID FILLED	2 mg	ORAL	unapproved drug other	7 sections
Concept DHA	HUMAN PRESCRIPTION DRUG LABEL	15	52747-621	CAPSULE, LIQUID FILLED	2 mg	ORAL	unapproved drug other	7 sections
PureVit DualFe Plus	HUMAN PRESCRIPTION DRUG LABEL	13	59088-112	CAPSULE	0.80 mg	ORAL	unapproved drug other	12 sections
Viva CT Prenatal	HUMAN PRESCRIPTION DRUG LABEL	12	64661-811	TABLET, CHEWABLE	1 mg	ORAL	UNAPPROVED DRUG OTHER	16 sections
TRICARE PRENATAL	HUMAN PRESCRIPTION DRUG LABEL	13	67112-101	TABLET, COATED	2 mg	ORAL	unapproved drug other	12 sections
TRICARE PRENATAL	HUMAN PRESCRIPTION DRUG LABEL	13	67112-101	TABLET, COATED	2 mg	ORAL	unapproved drug other	12 sections
TRICARE PRENATAL DHA ONE	HUMAN PRESCRIPTION DRUG LABEL	17	67112-401	CAPSULE, GELATIN COATED	2 mg	ORAL	unapproved drug other	12 sections
AQUATEC ALONGLIFE	HUMAN OTC DRUG LABEL	1	80224-1000	SOLUTION	0.03 mg	TOPICAL	OTC monograph not final	10 sections